HK1030418A1 - Process to produce 4-hydroxy-2-oxo-pyrane derivates useful as protease inhibitors - Google Patents

Process to produce 4-hydroxy-2-oxo-pyrane derivates useful as protease inhibitors

Info

Publication number
HK1030418A1
HK1030418A1 HK01101306A HK01101306A HK1030418A1 HK 1030418 A1 HK1030418 A1 HK 1030418A1 HK 01101306 A HK01101306 A HK 01101306A HK 01101306 A HK01101306 A HK 01101306A HK 1030418 A1 HK1030418 A1 HK 1030418A1
Authority
HK
Hong Kong
Prior art keywords
oxo
hydroxy
pyrane
produce
protease inhibitors
Prior art date
Application number
HK01101306A
Other languages
English (en)
Inventor
James R Gage
Robert C Kelly
Bradley D Hewitt
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of HK1030418A1 publication Critical patent/HK1030418A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
    • C07C47/277—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/48—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK01101306A 1997-09-11 2001-02-23 Process to produce 4-hydroxy-2-oxo-pyrane derivates useful as protease inhibitors HK1030418A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5861897P 1997-09-11 1997-09-11
PCT/US1998/017993 WO1999012919A1 (en) 1997-09-11 1998-09-03 Process to produce 4-hydroxy-2-oxo-pyrane derivates useful as protease inhibitors

Publications (1)

Publication Number Publication Date
HK1030418A1 true HK1030418A1 (en) 2001-05-04

Family

ID=22017924

Family Applications (3)

Application Number Title Priority Date Filing Date
HK01101306A HK1030418A1 (en) 1997-09-11 2001-02-23 Process to produce 4-hydroxy-2-oxo-pyrane derivates useful as protease inhibitors
HK04106501A HK1063776A1 (en) 1997-09-11 2004-08-30 compounds usefull to produce a protease inhibitors
HK07108806.0A HK1104027A1 (en) 1997-09-11 2007-08-14 Compounds useful to produce a protease inhibitor

Family Applications After (2)

Application Number Title Priority Date Filing Date
HK04106501A HK1063776A1 (en) 1997-09-11 2004-08-30 compounds usefull to produce a protease inhibitors
HK07108806.0A HK1104027A1 (en) 1997-09-11 2007-08-14 Compounds useful to produce a protease inhibitor

Country Status (21)

Country Link
US (2) US6077963A (de)
EP (1) EP1015441B1 (de)
JP (3) JP4462760B2 (de)
KR (1) KR100569771B1 (de)
CN (3) CN100471832C (de)
AT (1) ATE266654T1 (de)
CA (1) CA2300204C (de)
CZ (1) CZ298847B6 (de)
DE (1) DE69823844T2 (de)
DK (1) DK1015441T3 (de)
ES (1) ES2221199T3 (de)
FI (1) FI120973B (de)
HK (3) HK1030418A1 (de)
HU (1) HU228986B1 (de)
NO (1) NO321835B1 (de)
NZ (1) NZ503338A (de)
PL (1) PL193240B1 (de)
PT (1) PT1015441E (de)
RU (2) RU2223958C2 (de)
SK (1) SK284974B6 (de)
WO (1) WO1999012919A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1161427B1 (de) 1999-03-18 2002-10-23 PHARMACIA & UPJOHN COMPANY Verbesserte verfahren fur assymmetrische hydrogenation
US6552204B1 (en) * 2000-02-04 2003-04-22 Roche Colorado Corporation Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one
DE10108470A1 (de) * 2001-02-22 2002-09-05 Boehringer Ingelheim Pharma Verfahren zur Herstellung optisch aktiver Dihydropyrone
US6500963B2 (en) 2001-02-22 2002-12-31 Boehringer Ingelheim Pharma Kg Process for preparing optically active dihydropyrones
US6987123B2 (en) 2001-07-26 2006-01-17 Cadila Healthcare Limited Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
EP1894912B1 (de) 2002-02-07 2009-08-05 Sumitomo Chemical Company, Limited Verfahren zum Herstellen von racemischem 3-hydroxy-3-(2-phenylethyl)-Hexansäureester
DE10313118A1 (de) * 2003-03-24 2004-10-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Enantioselektive Hydrierung von Intermediaten bei der Tipranavir-Synthese
US7512945B2 (en) * 2003-12-29 2009-03-31 Intel Corporation Method and apparatus for scheduling the processing of commands for execution by cryptographic algorithm cores in a programmable network processor
CN100448836C (zh) * 2005-06-03 2009-01-07 浙江中贝化工有限公司 一种抗艾滋病药物关键中间体的制备方法
MX2008001541A (es) * 2005-08-24 2008-02-15 Pfizer Metodos para la preparacion de inhibidores de polimerasa del vhc.
CN101878553A (zh) * 2007-11-30 2010-11-03 株式会社半导体能源研究所 发光元件、发光装置以及电子装置
US8853393B2 (en) * 2011-07-29 2014-10-07 Anhui New Star Pharmaceutical Development Co., Ltd. Intermediate for preparing tapentadol or analogues thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1355667A (fr) * 1963-02-05 1964-03-20 Meci Materiel Elect Contr Gaine tubulaire pour électrode servant à la mesure du ph
FR1355668A (fr) * 1963-02-05 1964-03-20 Moteur rotatif à combustion interne perfectionné
FR2096877B1 (de) * 1970-07-09 1973-08-10 Hexachimie
JPH0665657B2 (ja) * 1984-11-08 1994-08-24 日本化薬株式会社 光学活性マンデル酸の製法
JPH072677B2 (ja) * 1988-02-19 1995-01-18 株式会社クラレ （±）―２―ヒドロキシ―４―フェニルブタン酸の光学分割法
JPH01221345A (ja) * 1988-02-27 1989-09-04 Ajinomoto Co Inc マンデル酸誘導体の光学分割方法
JP3084577B2 (ja) * 1991-09-27 2000-09-04 山川薬品工業株式会社 光学活性なアトロラクチン酸の製造方法および製造の中間体
JP3178086B2 (ja) * 1992-06-17 2001-06-18 山川薬品工業株式会社 光学活性α−メチルベンジルアミンの製造方法
ZA938019B (en) * 1992-11-13 1995-04-28 Upjohn Co Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses
DE69433705T2 (de) * 1993-11-19 2005-03-10 Parke, Davis & Company 5,6-Dihydropyronderivate als Proteaseinhibitoren und Antiviralmittel
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections

Also Published As

Publication number Publication date
US6077963A (en) 2000-06-20
EP1015441B1 (de) 2004-05-12
ES2221199T3 (es) 2004-12-16
PL339138A1 (en) 2000-12-04
RU2223958C2 (ru) 2004-02-20
HK1063776A1 (en) 2005-01-14
KR100569771B1 (ko) 2006-04-11
ATE266654T1 (de) 2004-05-15
US6265604B1 (en) 2001-07-24
CN1298714C (zh) 2007-02-07
HK1104027A1 (en) 2008-01-04
SK2262000A3 (en) 2000-10-09
CN1990452A (zh) 2007-07-04
CA2300204C (en) 2006-12-12
CZ298847B6 (cs) 2008-02-27
RU2263106C2 (ru) 2005-10-27
CN100471832C (zh) 2009-03-25
JP5016621B2 (ja) 2012-09-05
CN1284763C (zh) 2006-11-15
HUP0003593A3 (en) 2002-12-28
RU2003131081A (ru) 2005-04-10
KR20010023864A (ko) 2001-03-26
CN1511820A (zh) 2004-07-14
AU743496B2 (en) 2002-01-24
NO321835B1 (no) 2006-07-10
PL193240B1 (pl) 2007-01-31
HU228986B1 (en) 2013-07-29
JP2001515895A (ja) 2001-09-25
EP1015441A1 (de) 2000-07-05
CZ2000804A3 (cs) 2000-08-16
JP5266194B2 (ja) 2013-08-21
WO1999012919A1 (en) 1999-03-18
PT1015441E (pt) 2004-08-31
HUP0003593A2 (hu) 2001-02-28
JP2009138002A (ja) 2009-06-25
AU9296598A (en) 1999-03-29
DE69823844T2 (de) 2005-04-14
CN1268947A (zh) 2000-10-04
CA2300204A1 (en) 1999-03-18
JP4462760B2 (ja) 2010-05-12
SK284974B6 (sk) 2006-03-02
DE69823844D1 (de) 2004-06-17
JP2010090157A (ja) 2010-04-22
NZ503338A (en) 2002-03-01
NO20001274D0 (no) 2000-03-10
FI20000553A (fi) 2000-03-10
DK1015441T3 (da) 2004-07-26
NO20001274L (no) 2000-05-10
FI120973B (fi) 2010-05-31

Similar Documents

Publication Publication Date Title
HK1104027A1 (en) Compounds useful to produce a protease inhibitor
ZA919161B (en) Retroviral protease inhibitors.
EA199700186A1 (ru) Новые дипептидные амидины, используемые в качестве ингибиторов тромбина
ATE196466T1 (de) Inhibitoren retroviraler proteasen
PL322169A1 (en) Sulphonylalkanoylamino hydroxyethylaminosulphonamides as inhibitors of retroviral protease
NO945098D0 (no) Polymerisasjon av lignin ved alkalisk pH
TR200003885T2 (tr) Bilgisayar kullanımı için joypad
DE69917445D1 (de) Reinigung von carboxaldehyd
DE50112690D1 (de) Verfahren zur aufbereitung von pyrrolidon- und n-vinylpyrrolidon-rückständen
WO2002042413A3 (en) Methods and compositions involved in groucho-mediated differentiation
IL143051A0 (en) 1,4-diaryl-2-fluoro-1-buten- 3-ol compounds and their use in the preparation of 1,4-diaryl-2-fluoro-1,3-butadiene and 1,4-diaryl-2- fluoro-2-butene compounds
DE60039230D1 (de) Expression von proteolytischen enzymen in koji pilz in gegenwart von einer kohlenstoffquelle

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20180902